Joo Youn Cho
Overview
Explore the profile of Joo Youn Cho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ji S, Lee J, Cho J, Kim H, Jang Y, Kim E, et al.
J Korean Med Sci
. 2020 Mar;
35(11):e70.
PMID: 32193901
Background: Previously, a linked pharmacokinetic-pharmacodynamic model (the Kim model) of propofol with concurrent infusion of remifentanil was developed for children aged 2-12 years. There are few options for pharmacokinetic-pharmacodynamic model...
2.
Kim J, Kim A, Jang C, Jang I, Kim K, Cho J, et al.
J Korean Med Sci
. 2019 Apr;
34(13):e104.
PMID: 30950250
Background: The left internal thoracic artery (LITA) has been used as the first conduit of choice in coronary artery bypass grafting (CABG) because of excellent long-term patency and outcomes. However,...
3.
Suh H, Kim I, Cho J, Park S, Yoon S, Lee J, et al.
Infect Chemother
. 2017 Jun;
49(2):135-139.
PMID: 28608665
The posaconazole tablet formulation was developed to have improved bioavailability compared to the oral suspension. Here, we compared posaconazole plasma concentration (PPC) with the posaconazole oral suspension versus the tablet...
4.
Ban G, Ye Y, Kim S, Hur G, Kim J, Shim J, et al.
Allergy Asthma Immunol Res
. 2017 May;
9(4):378-382.
PMID: 28497926
The tools for asthma control assessment recommended by the current guideline are cognitive function- and effort-dependent, which is substantially impaired in the elderly. The aim of this study is to...
5.
Jun S, Jang I, Yoon S, Jang K, Yu K, Cho J, et al.
Antimicrob Agents Chemother
. 2017 Mar;
61(6).
PMID: 28348152
This study was a phase 1, single-center, randomized, double-blind, placebo-controlled, single-dosing, and dose-escalating study of intravenous SAL200. It is a new candidate drug for the treatment of antibiotic-resistant staphylococcal infections...
6.
Na Y, Gu G, Jung D, Kim Y, Na J, Woo J, et al.
J Immunol
. 2017 Mar;
198(7):3000.
PMID: 28320915
No abstract available.
7.
Na Y, Gu G, Jung D, Kim Y, Na J, Woo J, et al.
J Immunol
. 2016 Oct;
197(10):4101-4109.
PMID: 27742831
GM-CSF induces proinflammatory macrophages, but the underlying mechanisms have not been studied thus far. In this study, we investigated the mechanisms of how GM-CSF induces inflammatory macrophages. First, we observed...
8.
Choi K, Kim N, Jang I, Park Y, Cho J, Kim J, et al.
J Gastroenterol Hepatol
. 2009 Aug;
24(10):1617-24.
PMID: 19686407
Background And Aim: The lowest effective dose of proton pump inhibitors (PPI) for prevention of peptic ulcer rebleeding remains unclear. The objective of the present study was to evaluate whether...
9.
Cho J, Lim H, Yu K, Shim H, Jang I, Shin S
J Chromatogr B Analyt Technol Biomed Life Sci
. 2003 Oct;
795(2):179-86.
PMID: 14522022
A sensitive high-performance liquid chromatographic (HPLC) method with ultraviolet absorption detection (292 nm) was developed and validated for the determination of the new phosphodiesterase V inhibitor, DA-8159 (DA), in human...
10.
Cho J, Seo H, Yu K, Bae K, Yi S, Jang I, et al.
J Chromatogr B Analyt Technol Biomed Life Sci
. 2002 Dec;
784(1):25-31.
PMID: 12504179
A simple and sensitive high-performance liquid chromatographic with fluorescence detection method has been developed and validated for the determination of the new antitumor agent CKD-602 in human plasma. Plasma proteins...